Page last updated: 2024-08-22

stavudine and Atrophy

stavudine has been researched along with Atrophy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azu, OO; Chuturgoon, A; Masia, T; Naidu, EC; Naidu, JS; Nzemande, NF; Singh, S1
Bratt, GA; Eriksson, LE; Nilsson Schönnesson, L1
Borgonovo, S; Brambilla, P; Cafarelli, L; Giacomet, V; Mora, S; Viganò, A; Zamproni, I; Zuccotti, G1

Trials

1 trial(s) available for stavudine and Atrophy

ArticleYear
Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz.
    Antiviral therapy, 2007, Volume: 12, Issue:3

    Topics: Absorptiometry, Photon; Adenine; Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atrophy; Benzoxazines; Body Composition; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclopropanes; Female; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Italy; Male; Organophosphonates; Prospective Studies; Protease Inhibitors; Stavudine; Tenofovir; Time Factors; Treatment Outcome; Viral Load

2007

Other Studies

2 other study(ies) available for stavudine and Atrophy

ArticleYear
Testicular histomorphologic and stereological alterations following short-term treatment with highly active antiretroviral drugs (HAART) in an experimental animal model.
    Andrology, 2014, Volume: 2, Issue:5

    Topics: alpha-Tocopherol; Animals; Anti-HIV Agents; Antioxidants; Antiretroviral Therapy, Highly Active; Ascorbic Acid; Atrophy; Lamivudine; Male; Models, Animal; Necrosis; Nevirapine; Random Allocation; Rats; Rats, Sprague-Dawley; Seminiferous Tubules; Stavudine

2014
Lipoatrophy of the footpad in HIV-treated patients is associated with increased PAI-1.
    Biological research for nursing, 2011, Volume: 13, Issue:1

    Topics: Adipose Tissue; Adult; Anti-HIV Agents; Atrophy; Cardiovascular Diseases; Cross-Sectional Studies; Didanosine; Foot; HIV Infections; Humans; Logistic Models; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prevalence; Risk Factors; Stavudine

2011